PMID- 33154086 OWN - NLM STAT- MEDLINE DCOM- 20211124 LR - 20220829 IS - 2052-4439 (Electronic) IS - 2052-4439 (Linking) VI - 7 IP - 1 DP - 2020 Nov TI - Novel electronic adherence monitoring devices in children with asthma: a mixed-methods study. LID - 10.1136/bmjresp-2020-000589 [doi] LID - e000589 AB - INTRODUCTION: Adherence monitoring to inhaled corticosteroids is an essential component of asthma management. Electronic monitoring devices (EMD) provide objective data on date, time and number of actuations. However, most give no information on inhalation. Novel EMD (NEMD) platforms have the potential to monitor both activation and inhalation. AIM: To assess the feasibility of NEMDs, in terms of usability, acceptability to patients and healthcare professionals and accuracy. METHODS: This was an open-label, prospective, mixed-methods, pragmatic randomised study. Children with asthma attending specialist tertiary care were randomised to one of four NEMD: Remote Directly Observed Therapy (R-DOT), Hailie Smartinhaler, INhaler Compliance Assessment device (INCA) and the Rafi-tone App. Following monitoring, participants were invited to focus groups or one-to-one interviews. Usability and acceptability were evaluated using themes identified from the focus groups and interviews. Adherence accuracy was determined using adherence data from each NEMD. RESULTS: Thirty-five children were recruited; 18 (51%), (11 males, median age 13.5 (7-16) years) completed monitoring, 14 (78%) provided feedback. Participants identified various features such as ease of use and minimal effort as desirable criteria for an NEMD. The Hailie and INCA fulfilled these criteria and were able to record both actuation and inhalation. Negative themes included a 'Big Brother' effect and costs. CONCLUSION: There was no 'one size fits all', as participants identified advantages and disadvantages for each NEMD. Devices that can easily calculate adherence to activation and inhalation have the potential to have greatest utility in clinical practice. Each NEMD has different functionality and therefore choice of platform should be determined by the needs of the patient and healthcare professional. CI - (c) Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. FAU - Makhecha, Sukeshi AU - Makhecha S AUID- ORCID: 0000-0002-6816-7478 AD - Paediatrics, Respiratory, Royal Brompton Hospital, London, London, UK. FAU - Chan, Amy AU - Chan A AD - The University of Auckland School of Pharmacy, Auckland, Auckland, New Zealand. AD - Centre of Behavioural Medicine, School of Pharmacy, UCL, London, London, UK. FAU - Pearce, Christina AU - Pearce C AD - Centre of Behavioural Medicine, School of Pharmacy, UCL, London, London, UK. FAU - Jamalzadeh, Angela AU - Jamalzadeh A AD - Paediatrics, Respiratory, Royal Brompton Hospital, London, London, UK. FAU - Fleming, Louise AU - Fleming L AD - Paediatrics, Respiratory, Royal Brompton Hospital, London, London, UK l.fleming@rbht.nhs.uk. AD - Imperial College London, London, London, UK. LA - eng PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't PL - England TA - BMJ Open Respir Res JT - BMJ open respiratory research JID - 101638061 SB - IM MH - Administration, Inhalation MH - Adolescent MH - *Asthma/drug therapy MH - Child MH - Electronics MH - Female MH - Humans MH - Male MH - *Medication Adherence MH - Prospective Studies PMC - PMC7646352 OTO - NOTNLM OT - asthma OT - inhaler devices OT - paediatric asthma COIS- Competing interests: None declared. EDAT- 2020/11/07 06:00 MHDA- 2021/11/25 06:00 PMCR- 2020/11/05 CRDT- 2020/11/06 05:51 PHST- 2020/04/02 00:00 [received] PHST- 2020/09/27 00:00 [revised] PHST- 2020/09/29 00:00 [accepted] PHST- 2020/11/06 05:51 [entrez] PHST- 2020/11/07 06:00 [pubmed] PHST- 2021/11/25 06:00 [medline] PHST- 2020/11/05 00:00 [pmc-release] AID - 7/1/e000589 [pii] AID - bmjresp-2020-000589 [pii] AID - 10.1136/bmjresp-2020-000589 [doi] PST - ppublish SO - BMJ Open Respir Res. 2020 Nov;7(1):e000589. doi: 10.1136/bmjresp-2020-000589.